This article gives an overview of the implications of the use of galantamine (Reminyl) to treat autism.
Galantamine is an acetylcholinesterase inhibitor that is classified as an anti-dementia drug. Officially, galantamine is indicated only for the treatment of Alzheimer's disease. However, recent clinical trials have encouraged physicians to write off-label prescriptions for acetylcholinesterase inhibitors to treat other forms of brain disorders, including autism. Galantamine is able to help the brain release chemicals, which are critical for sending information between different parts of the brain. In this way, galantamine may be able to improve many brain functions and not just treat problems associated with Alzheimer's disease. The authors concluded by painting an optimistic future of the ability of drugs to improve brain function.